Joshua A. Gordon, MD, PhD

Viewpoints

NIMH Supports Evidence-Based Treatments for Schizophrenia

January 15, 2019

In this Viewpoint article, Dr Joshua Gordon, Director of the NIMH, responds to points raised by Torrey et al regarding the decrease in the number of medication trials for...